This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 2016-2018.
Company Filing History:
Years Active: 2016-2018
Title: The Innovative Contributions of Herve Schaffhauser
Introduction
Herve Schaffhauser is a notable inventor based in Habsheim, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various medical conditions. With a total of three patents to his name, Schaffhauser's work has the potential to impact the treatment of serious health issues.
Latest Patents
Schaffhauser's latest patents include innovative compounds such as pyrrolopyridine or pyrazolopyridine derivatives. These compounds are defined by specific formulas that aim to provide therapeutic benefits. Another significant patent involves indol and indazol derivatives, which are designed for the treatment or prophylaxis of Alzheimer's disease, cognitive impairment, schizophrenia, pain, and sleep disorders. These advancements highlight his commitment to addressing critical health challenges through innovative chemistry.
Career Highlights
Throughout his career, Schaffhauser has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to develop and refine his inventions, contributing to the advancement of medical science.
Collaborations
Some of Schaffhauser's notable coworkers include Katrin Groebke Zbinden and Alexander Flohr. Their collaborative efforts have likely played a role in the successful development of his patented compounds.
Conclusion
Herve Schaffhauser's innovative work in pharmaceuticals demonstrates his dedication to improving health outcomes through scientific research and development. His patents reflect a significant contribution to the field, showcasing the potential for new treatments for various medical conditions.